HMN 2024: How New drug strategy targets rare immune disorders’ genetic roots
Health Medicine Network,
Do you know New drug strategy targets rare immune disorders’ genetic roots in 2024 Credit: Journal of Clinical Immunology (2024).
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia
Overview of attention for article published in Journal of Clinical Immunology, September 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Readers on
- mendeley
- 18 Mendeley